|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 19734322.1 (espacenet) (Federated) (European Patent Register), 20190619 | | Patent/reg. no. and date | DK/EP 3810279, 20230913 | | Publication date | 20210428 | | Priority no. and date | GB 201810058, 20180619 | | EP pub. no. and date |
EP 3810279 20210428 | | Effective date | | | Applicant/owner | Cytovation ASA, Solheimsgaten 11
5058 Bergen, NO | | Applicant ref. no. | P83227DK01 | | Inventor | PRESTEGARDEN, Lars,
5058 Bergen, NO | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 38/16 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) | | Title | KOMBINATION OMFATTENDE ANVENDELSE AF EN OLIGOPEPTIDFORBINDELSE OG ET ANTI-PD-1- ELLER PD-L1-ANTISTOF TIL ANVENDELSE TIL BEHANDLING AF NEOPLASTISKE TILSTANDE | | Int. application no. | EP2019066295 | | Int. publication no. | WO2019243471 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
